Results 181 to 190 of about 29,868 (281)

Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study

JEADV Clinical Practice, Volume 5, Issue 2, Page 495-501, June 2026.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru, Nesrine Brahimi, Haleh Zabihi, Cathryn Sibbald, Kyle Seigel, Delaram Shojaei, Eric McMullen, Afsaneh Alavi, Lily Archaempong, Aaron M. Drucker, Adam Weizman, Kenneth Croitoru, Robert Inman, Vincent Piguet   +13 more
wiley   +1 more source

Exploring the Role of Skin Microbiota in Autoimmune Skin Diseases from a Bidirectional Mendelian Randomization Perspective. [PDF]

Clin Cosmet Investig Dermatol
Wang J, Wang X, Tao X, Yang Q, Zhang M, Wang Y, Liu S.   +6 more
europepmc   +1 more source

Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective

JEADV Clinical Practice, Volume 5, Issue 2, Page 402-414, June 2026.
Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek, Iris Zalaudek, Karolina Zarańska, Bożena Cybulska‐Stopa   +3 more
wiley   +1 more source

Concurrent Drug-induced Rowell Syndrome and Acute Generalized Exanthematous Pustulosis. [PDF]

Acta Derm Venereol
Hsu YA, Chu KY, Lan CE.
europepmc   +1 more source

An Open‐Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's Disease

Movement Disorders, Volume 41, Issue 6, Page 1492-1501, June 2026.
Complement activation is implicated in Huntington's disease; ANX005 is a potent inhibitor of component C1q. ANX005 exhibited a generally manageable safety profile with rapid reduction in C1q in the cerebrospinal fluid. Functional ability on composite Unified Huntington's Disease Rating Scale and total functional capacity was maintained, with potential ...
Rajeev Kumar, Pinky Agarwal, Karen Anderson, Daniel Claassen, Marissa Dean, Andrew Duker, Burton Scott, Benjamin Hoehn, Ann Mongan, Ping Lin, Ellen Cahir‐McFarland, Lori Taylor, Glenn Morrison, Ted Yednock, Sanjay Keswani, Henk‐Andre Kroon   +15 more
wiley   +1 more source

Papulonodular mucinosis with or without systemic lupus erythematosus: a retrospective study. [PDF]

Postepy Dermatol Alergol
Gan L, Ding M, Zhang W, Sun J, Feng S, Chen H.   +5 more
europepmc   +1 more source

Update on cutaneous lupus erythematosus

Indian Journal of Dermatology, Venereology, and Leprology, 2012
openaire   +2 more sources

Cell membrane‐coated nanoparticles for dermatological diseases

VIEW, Volume 7, Issue 3, June 2026.
Skin disorders are challenging to treat due to complex barrier functions and limited conventional therapies. Biomimetic cell membrane‐coated nanoparticles (CM‐NPs) offer a superior nanomedicine approach by evading immune detection and enabling precise targeting.
Shuaijun Zou, Baojie Zhang, Yuanjie Zhu
wiley   +1 more source

Sex-based clinical and immunological differences across lupus erythematosus subtypes: a cross-sectional multicentre study from China. [PDF]

Lupus Sci Med
Pan Y, Jin H, Zhou S, Ying Z, Bai L, Lu Q.   +5 more
europepmc   +1 more source

Impact of Allergic Contact Dermatitis on Health‐Related Quality of Life: A Cross‐Sectional Case–Control Study in a Spanish Population

Contact Dermatitis, Volume 94, Issue 6, Page 592-602, June 2026.
Allergic contact dermatitis markedly impairs quality of life (QoL) across symptoms, functioning and emotional domains. Using DLQI, Skindex‐29 and EQ‐5D‐5L, our study demonstrates a substantial multidimensional burden and highlights the need for routine, patient‐centred QoL assessment in clinical management.
Francisco José Navarro‐Triviño, Álvaro Prados‐Carmona, Ricardo Ruiz‐Villaverde, María Isabel Peralta‐Ramírez   +3 more
wiley   +1 more source